Patients with chronic conditions who are failing on conventional therapies may be suffering from undiagnosed major depression ...

Major depression fluctuates during and after pregnancy but has the highest prevalence two weeks after giving birth, a ...

Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the presentation of data from a ...

A newer brain stimulation therapy matched ECT for depression while causing less memory loss, offering a potential option for patients concerned about cognitive side effects.

Scientists have identified two specific types of brain cells that behave differently in people with depression, offering a ...

While many brain-computer interface companies are focused on helping paralyzed people communicate, Motif Neurotech is ...

Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...

Treatment with oral semaglutide (Rybelsus) significantly improved motivation measures in patients with major depressive ...

In the largest mental health study of its kind, Australian researchers have found that the prevalence of major depression ...